Correction: Efficacy of afatinib, an irreversible ErbB family blocker, in the treatment of intracerebral metastases of non-small cell lung cancer in mice.

IF 6.9 1区医学 Q1 CHEMISTRY, MULTIDISCIPLINARY

Acta Pharmacologica Sinica Pub Date : 2025-04-09 DOI:10.1038/s41401-025-01542-6

Shi-Rong Zhang, Lu-Cheng Zhu, Yan-Ping Jiang, Jing Zhang, Ru-Jun Xu, Ya-Si Xu, Bing Xia, Sheng-Lin Ma

引用次数: 0

查看原文本刊更多论文

更正：不可逆ErbB家族阻滞剂阿法替尼治疗小鼠非小细胞肺癌脑内转移的疗效。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Acta Pharmacologica Sinica 医学-化学综合

CiteScore

15.10

自引率

2.40%

发文量

4365

审稿时长

2 months

期刊介绍： APS (Acta Pharmacologica Sinica) welcomes submissions from diverse areas of pharmacology and the life sciences. While we encourage contributions across a broad spectrum, topics of particular interest include, but are not limited to: anticancer pharmacology, cardiovascular and pulmonary pharmacology, clinical pharmacology, drug discovery, gastrointestinal and hepatic pharmacology, genitourinary, renal, and endocrine pharmacology, immunopharmacology and inflammation, molecular and cellular pharmacology, neuropharmacology, pharmaceutics, and pharmacokinetics. Join us in sharing your research and insights in pharmacology and the life sciences.